RBMO insights: issue 1
Reproductive BioMedicine Online
An international journal dedicated to biomedical research on human conception and the welfare of the human embryo
We have a new Newsletter feature in LinkedIn and would like to try it out as a way to shine a light from another angle onto the most interesting and popular papers published in Reproductive Biomedicine Online.
Introducing RBMO insights!
In our first newsletter, we bring you a collection of the most viewed articles in the last month that our readers have been picking up, including a couple of older papers among the latest articles; which ?include two summary overviews of recent guidelines and statements from world-leading bodies, WHO and PGDIS.
A full roundup of recent journal highlights, Editor’s Choice, Hot Topics, and Reviews can be found in our quarterly RBMO Digest ??
We hope you find this Newsletter an interesting and useful feature.?We will use this to bring you different highlights from the journal, our sections, authors and community in the future.
If you are not on LinkedIn, or you would like to receive email versions of these newsletters, then please subscribe to our mailing list.
REVIEW: A paradigmatic shift in the care of male factor infertility – how can the recommendations for basic semen examination in the 6th edition of the WHO manual and the ISO 23162:2021 standard help? Lars Bj?rndahl
Published online: March 14, 2022
This review discusses how the available distribution of data from men in couples achieving pregnancy should be interpreted. Another important aspect is the use of human sperm morphology for better understanding of functions and disorders of the male reproductive organs to get increased focus on men's reproductive health.
REVIEW: PGDIS Position Statement on the Transfer of Mosaic Embryos 2021 Leigh et al.
Published online: March 20, 2022
Since the release of the previous PGDIS Position Statement on mosaicism 2019, there has remained uncertainty about implications of mosaic embryo transfer. This paper reviewed the most recent information and provides an updated recommendations to test laboratories, clinics, clinicians and genetic counsellors regarding the transfer of mosaic embryos, replacing previous 2016 and 2019 PGDIS documents.
Dimitriadis et al.
Published online: November 11, 2021
Artificial intelligence (AI) has the potential to be used as a tool to assist embryologists in daily activities such as performing morphological assessments and in selecting embryos for transfer. AI also has the potential to help clinicians make decisions and help patients achieve their goal of having a healthy baby.
ARTICLE: Female gender pre-selection by maternal diet in combination with timing of sexual intercourse – a prospective study Noorlander et al.
Published online: September 1, 2010
The results of this study indicate that maternal diet composition together with timing of sexual intercourse and use of a prediction rule will lead to an increased probability of a girl baby. It is important that both diet and timing are followed correctly, which requires of the mother both willpower and meticulousness.
领英推荐
REVIEW: Time to conceive after myomectomy: should we advise a minimum time interval? A systematic review Margueritte et al.
Published online: May 30, 2021
From the literature analysis presented in this paper, there isn’t any evidence to advise a minimal time interval to conceive after myomectomy as mean time from myomectomy to pregnancy is about a year and a half. Risk of uterine rupture after myomectomy is minimal and not correlated with time interval from myomectomy to pregnancy.
EDITORIAL: Towards the global coverage of a unified registry of IVF outcomes Bart CJM Fauser
Published online: December 14, 2018
IVF is generally considered one of the best-registered procedures in medicine. Today, 40 years after its heavily criticized clinical introduction, IVF is available as a successful treatment for infertility almost all over the world. Over 8 million IVF children have been born, and over 2.5 million cycles are being performed every year, resulting in over 500,000 deliveries annually. There is much to be proud of in such distinct achievements, yet many challenges remain.
COUNTERCURRENT: ‘The way to improve ART outcomes is to introduce more technologies in the laboratory’ David K. Gardner
Published online: November 2, 2021
Technological advances which facilitate automation and standardisation in the ART lab can impact success measures such as time to pregnancy, cumulative pregnancy per oocyte retrieval, and the health of the resultant child, alongside clinical performance consistency and quality management. This countercurrent contribution emphasises how such new technologies could help more patients become parents of healthy children in the shortest possible time.
RBMO LIVE: Episode 6
The next episode of our quarterly webinar series will be Tuesday 7th June, themed around our Reproduction, Technology and Society section. Registration will open soon. Keep an eye on the RBMO Twitter and LinkedIn accounts for news and updates. A recording of the previous session is available on the i3 website, highlighting advances and controversial perspectives on developing Lab Tech, hosted by Bart Fauser and Mina Alikani with David Gardner, Marcos Meseguer, Lorena Bori Arnal, Romulado Sciorio, and Ana Pereira Daoud
We hope you found this helpful - let us know what you thought of it, and look out for another edition next month, and see how we develop this format.
RBMO Editorial Team